Clinical and microbiological characteristics of bloodstream infections in a tertiary hospital in Maceió, Alagoas, Brazil

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 2, 2010, Pages 175-179

  Tenório, Maria Tereza Freitas ^a,b   Porfirio, Zenaldo ^a,b   Lopes, Antonio Carlos ^a   Cendon, Sonia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Medicina   (Brazil)

Author keywords

Bacteremia; Blood cultures; Bloodstream infections; Spesis

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; BRAZIL; CATHETER INFECTION; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFECTION SENSITIVITY; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NEUROPATHY; NONHUMAN; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; URINARY TRACT INFECTION; EPIDEMIOLOGY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; SEPSIS; SEVERITY OF ILLNESS INDEX;

BRAZIL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 77954774985     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000200011     Document Type: Article

References (31)

1. Pittet D. Nosocomial bloodstream infections: secular trends in rates, mortality, and contributions to total hospital deaths. Arch Intern Med 1995; 155:1177-84.
2. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections. Mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17(8):552-57.
3. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med September 1999; 160 (3):976-81.
4. Bernard GR, Vincent JL, Laterre PF et al. Effi cacy and safety of recombinant human activated protein C for severe sepsis. The New England Journal of Medicine 2001; 344:699-709.
5. Pizzolatti ML, Moritz RD, Andrade J. Avaliação do conhecimento dos profi ssionais da área de medicina de urgência sobre os critérios de defi nição de SIRS, Sepse, Sepse Grave e Choque Séptico. Revista Brasileira Terapia Intensiva (RBTI) 2004; 16(4):210-4.
6. Ibrahim EH, Sherman G, Ward S et al. The infl uence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
7. Russel JA. Management of Sepsis. N. Engl. J Med October 19, 2006; 355:16.
8. Fernandes AT, Furtado JJD, Porfírio FMV, Cavalcante NJF. Infecção hospitalar da corrente sanguínea. In: Fernandes AT. (editores) Controle de infecção hospitalar e suas interfaces na área de saúde. 2000; cap. 23:580-606.
9. Carvalho PRA, Trotta EA. Avanços no diagnóstico e tratamento da sepse. J Pediatr (Rio J) 2003; 79 (Supl. 2):S195-S204.
10. Angus D, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001; 29:1303-10.
11. Luz KG, Marinho LAC, Tavares W. Sepse. In: Tavares W, Marinho LAC (editores). Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias. São Paulo: Atheneu, 2005; cap. 142:941-50.
12. Hallage NM. Epidemiologia das infecções associadas a cateter intravascular. In: Infecção associada ao uso de cateteres vasculares. Cap. 2. 3 ed. São Paulo: APECIH - Associação Paulista de Estudos e Controle de Infecção Hospitalar, 2005; 6-13.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992; 20:864-74.
14. Pinheiro S. Predicao de Risco de Infecção Hospitalar para Pa-cientes em Unidade de Terapia Intensiva. Mestrado em INFEC-TOLOGIA. Universidade Federal de Sao Paulo, UNIFESP, Brasil. Ano de Obtencao: 1998.
15. Silva E, Pinheiro C, Michel J.V. Epidemiologia. Revista Bra-sileira de Terapia Intensiva - RBTI/ Consenso Brasileiro de Sepse Parte I. abr/jun 2004; 16(2):97-108.
16. Rangel-Frausto MS, Pittet D, Costigan M et al. The natural history of the the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA, 1995; 273:117-23.
17. Alberti C, Brun-Buisson C, Burchardi H et al. Epidemiology of sepsis and infection in ICU patients from an international multi-centre cohort study. Intensive Care Med, 2002; 28:108-21.
18. Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 2003; 348:1546-54.
19. Lemos RLL, David CMN, Oliveira GMM, Amitrano DA, Luiz RR. Associação do SOFA com a mortalidade de idosos com sepse grave e choque séptico. RBTI 2005; 17(4):246-50.
20. Brun-Buisson C, Doyon F, Carlet J et al. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and ward of 24 hospitals. French Bacteremia Sepsis Study Group. Am J Repor Crit Care Med 1996; 154:617-24.
21. Medeiros EAS, Menezes FG, Valle LMC. Pneumonias bacterianas associadas à assistência à saúde. In: Prevenção das infeções hos-pitalares do trato respiratório. Cap. 1. 2 ed. São Paulo: APECIH -Associação Paulista de Estudos e Controle de Infecção Hospitalar, 2005; 1-17.
22. CDC. Guidelines for the Prevention of Catheter-Related Infections. MMWR Recommendations and Reports 2002/51(RR10); 1-26.
23. Menegotto FR, Picoli SU. Staphylococcus aureus oxacilina resist-ente (MRSA): incidencia de cepas adquiridas na comunidade (CA-MRSA) e importancia da pesquisa e descolonização em hospital. RBAC 2007; 39(2):147-50.
24. Ribeiro J, Boyce JM, Zancanaro PQ. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil. Braz J Infect Dis. feb 2005; 9(1).
25. Silva E, Pinheiro C, Michel Junior V. Epidemiologia. Revista Bra-sileira de Terapia Intensiva - RBTI/ Consenso Brasileiro de Sepse Parte I. abr/jun 2004; 16(2):97-108.
26. Rello J, Ricart M, Mirelis B et al. Nosocomial Bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994; 20:94-8.
27. Silva E, Pedro MA, Sogayar ACB et al. Brazilian Sepsis Epidemio-logical Study (BASES study). Critical Care, 2004; 8:R251-R260.
28. Brun-Buisson C, Doyon F, Carlet J et al. Incidence, risk factors, and outcome of severe sepsis and sepsis shock in adults. A mul-ticenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274:968-74.
29. Sands KE, Bates DW, Lanken PN et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA, 1997; 278:234-40.
30. Dellinger RP. The surviving sepsis campaign. Revista Brasileira Terapia Intensiva (RBTI) 2004; 16(4):257-60.
31. Dellinger RP et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36 (1):296-327.